Literature DB >> 15037605

Protein kinase C (PKC) betaII induces cell invasion through a Ras/Mek-, PKC iota/Rac 1-dependent signaling pathway.

Jie Zhang1, Panos Z Anastasiadis, Yan Liu, E Aubrey Thompson, Alan P Fields.   

Abstract

Protein kinase C betaII (PKCbetaII) promotes colon carcinogenesis. Expression of PKCbetaII in the colon of transgenic mice induces hyperproliferation and increased susceptibility to colon cancer. To determine molecular mechanisms by which PKCbetaII promotes colon cancer, we established rat intestinal epithelial (RIE) cells stably expressing PKCbetaII. Here we show that RIE/PKCbetaII cells acquire an invasive phenotype that is blocked by the PKCbeta inhibitor LY379196. Invasion is not observed in RIE cells expressing a kinase-deficient PKCbetaII, indicating that PKCbetaII activity is required for the invasive phenotype. PKCbetaII induces activation of K-Ras and the Ras effector, Rac1, in RIE/PKCbetaII cells. PKCbetaII-mediated invasion is blocked by the Mek inhibitor, U0126, and by expression of either dominant negative Rac1 or kinase-deficient atypical PKCiota. Expression of constitutively active Rac1 induces Mek activation and invasion in RIE cells, indicating that Rac1 is the critical downstream effector of PKCbetaII-mediated invasion. Taken together, our results define a novel PKCbetaII --> Ras --> PKCiota /Rac1 --> Mek signaling pathway that induces invasion in intestinal epithelial cells. This pathway provides a plausible mechanism by which PKCbetaII promotes colon carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15037605     DOI: 10.1074/jbc.M400774200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  53 in total

1.  Protein kinase Ciota is required for pancreatic cancer cell transformed growth and tumorigenesis.

Authors:  Michele L Scotti; William R Bamlet; Thomas C Smyrk; Alan P Fields; Nicole R Murray
Journal:  Cancer Res       Date:  2010-02-23       Impact factor: 12.701

2.  Oncogenic activity of Ect2 is regulated through protein kinase C iota-mediated phosphorylation.

Authors:  Verline Justilien; Lee Jameison; Channing J Der; Kent L Rossman; Alan P Fields
Journal:  J Biol Chem       Date:  2010-12-28       Impact factor: 5.157

3.  MHC class II deprivation impairs CD4 T cell motility and responsiveness to antigen-bearing dendritic cells in vivo.

Authors:  Ursula B Fischer; Erica L Jacovetty; Ricardo B Medeiros; Brian D Goudy; Traci Zell; Jeannie-Beth Swanson; Elizabeth Lorenz; Yoji Shimizu; Mark J Miller; Alexander Khoruts; Elizabeth Ingulli
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-13       Impact factor: 11.205

4.  Matrix metalloproteinase-9 is differentially expressed in nonfunctioning invasive and noninvasive pituitary adenomas and increases invasion in human pituitary adenoma cell line.

Authors:  Isa M Hussaini; Christy Trotter; Yunge Zhao; Rana Abdel-Fattah; Samson Amos; Aizhen Xiao; Crystal U Agi; Gerard T Redpath; Zixing Fang; Gilberto K K Leung; Maria Beatriz S Lopes; Edward R Laws
Journal:  Am J Pathol       Date:  2007-01       Impact factor: 4.307

5.  Differential regulation of RANTES and IL-8 expression in lung adenocarcinoma cells.

Authors:  Corinne Henriquet; Claire Gougat; Audrey Combes; Gwendal Lazennec; Marc Mathieu
Journal:  Lung Cancer       Date:  2007-01-17       Impact factor: 5.705

6.  Protein kinase C isozymes as therapeutic targets for treatment of human cancers.

Authors:  Alan P Fields; Nicole R Murray
Journal:  Adv Enzyme Regul       Date:  2008-03-18

Review 7.  Protein kinase C iota: human oncogene, prognostic marker and therapeutic target.

Authors:  Alan P Fields; Roderick P Regala
Journal:  Pharmacol Res       Date:  2007-05-05       Impact factor: 7.658

8.  Protein kinase C betaII and PKCiota/lambda: collaborating partners in colon cancer promotion and progression.

Authors:  Nicole R Murray; Justin Weems; Ursula Braun; Michael Leitges; Alan P Fields
Journal:  Cancer Res       Date:  2009-01-15       Impact factor: 12.701

9.  miR-217-5p induces apoptosis by directly targeting PRKCI, BAG3, ITGAV and MAPK1 in colorectal cancer cells.

Authors:  Marion Flum; Michael Kleemann; Helga Schneider; Benjamin Weis; Simon Fischer; René Handrick; Kerstin Otte
Journal:  J Cell Commun Signal       Date:  2017-09-14       Impact factor: 5.782

10.  A novel quinoline, MT477: suppresses cell signaling through Ras molecular pathway, inhibits PKC activity, and demonstrates in vivo anti-tumor activity against human carcinoma cell lines.

Authors:  Piotr Jasinski; Brandon Welsh; Jorge Galvez; David Land; Pawel Zwolak; Lori Ghandi; Kaoru Terai; Arkadiusz Z Dudek
Journal:  Invest New Drugs       Date:  2007-10-24       Impact factor: 3.850

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.